Prostatic Urethral Lift Versus Medical Therapy: Examining the Impact on Sexual Function in Men with Benign Prostatic Hyperplasia

Claus G. Roehrborn, Daniel B. Rukstalis

Research output: Contribution to journalArticlepeer-review

Abstract

Sexual function is an important aspect of the aging male's quality of life and a valuable outcome to consider for men undergoing treatment for benign prostatic hyperplasia (BPH). In this non–head-to-head comparison, we demonstrate that the prostatic urethral lift (PUL) is superior in three sexual function domains (erectile function, ejaculatory function, and sexual satisfaction) compared to medical therapy. Our findings challenge the idea that medical therapy is the most conservative minimally invasive BPH treatment and demonstrate that PUL is a suitable treatment for BPH patients who wish to preserve and possibly improve sexual function.

Original languageEnglish (US)
JournalEuropean Urology Focus
DOIs
StateAccepted/In press - 2021

Keywords

  • 5α-Reductase inhibitor
  • Benign prostatic hyperplasia
  • Ejaculatory function
  • Erectile function
  • Lower urinary tract symptoms
  • Prostatic urethral lift
  • Sexual satisfaction
  • α blocker

ASJC Scopus subject areas

  • Urology

Fingerprint

Dive into the research topics of 'Prostatic Urethral Lift Versus Medical Therapy: Examining the Impact on Sexual Function in Men with Benign Prostatic Hyperplasia'. Together they form a unique fingerprint.

Cite this